Virtual Event | May 19, 2025

Decoding mRNA's Future: Understanding The Impact Of New Regulatory Guidance

Source: Advancing RNA

In this Advancing RNA Live discussion, editorial and community director Anna Rose Welch sat down with CureVac’s Ulrike Jägle and Eliquent Life Science’s Tiffany Lucas to take a closer look at the latest mRNA regulatory guidance. They identified the biggest challenges the industry faced in navigating these guidances and explored the overarching learnings and best practices mRNA developers could apply across their programs, regardless of therapeutic approach.

access the Virtual Event!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.

Subscribe to Advancing RNA X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Advancing RNA

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)